An in vitro assay revealed that SPP-ARV-825 significantly inhibited glioma cell proliferation, induced G0/G1 cell cycle arrest, and triggered apoptosis through BRD4 degradation compared to free ARV-825. The gene discussed is BRD4; the disease is central nervous system cancer.